| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |